T0	Interventions 38 96	oral JAK inhibitor tofacitinib (CP-690,550) versus placebo
T1	Interventions 117 140	background methotrexate
T2	Interventions 216 235	methotrexate alone.
T3	Interventions 313 355	oral tofacitinib (CP-690,550) with placebo
T4	Interventions 463 481	methotrexate (MTX)
T5	Interventions 517 533	MTX monotherapy.
T6	Interventions 651 673	placebo or tofacitinib
T7	Interventions 835 839	MTX.
T8	Interventions 1030 1041	tofacitinib
T9	Interventions 1257 1268	for placebo
T10	Interventions 1996 2007	response to
T11	Interventions 2037 2060	addition of tofacitinib